Mechanisms of action of chemical carcinogens and their role in structure-activity relationships (SAR) analysis and risk assessment

Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens

Volumn , Issue , 2003, Pages 41-80

  Woo, Yin Tak ^a   Lai, David Y ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974803514     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203010822     Document Type: Chapter

References (183)

1. Arcos, J.C. and Argus, M.F., Multifactor interaction network of carcinogenesis: a “tour guide,” in Chemical Induction of Cancer, Modulation and Combination Effects, Arcos, J.C., Argus, M.F., and Woo, Y.-T., Eds., Birkhauser Boston, Cambridge, 1995, 1.
2. Helma, C. et al., The Predictive Toxicology Challenge for 2000-2001, working notes, 12th European Conf. on Machine Learning/5th European Conf. on Principles and Practice of Knowledge Discovery in Databases, Freiburg, Germany, 2001.
3. Benigni, R. and Richard, A.M., QSARs of mutagens and carcinogens: two case studies illustrating problems in the construction of models for noncongeneric chemicals, Mutat. Res., 371, 29, 1996.
4. Benigni, R. et al., Quantitative structure-activity relationships of mutagenic and carcinogenic aromatic amines, Chem. Rev., 100, 3697, 2000.
5. Benigni, R. and Passerini, L., Carcinogenicity of the aromatic amines: from structure- activity relationships to mechanism of action and risk assessment, Mutat. Res., 511, 191, 2002.
6. Franke, R. et al., Prediction of rodent carcinogenicity of aromatic amines: a quantitative structure-activity relationships model, Carcinogenesis, 22, 1561, 2001.
7. Woo, Y.-T. et al., Development of structure-activity relationship rules for predicting carcinogenic potential of chemicals, Toxicol. Lett., 79, 219, 1995.
8. Arcos, J.C., Woo, Y.-T., and Argus, M.F. (in collaboration with D. Lai), Chemical Induction of Cancer: Structural Bases and Biological Mechanisms, Vol. IIIA, Aliphatic Carcinogens, Academic Press, New York, 1985.
9. Woo, Y.-T. et al., Chemical Induction of Cancer: Structural Bases and Biological Mechanisms, Vol. IIIB, Aliphatic and Polyhalogenated Carcinogens, Academic Press, New York, 1985.
10. Woo, Y.-T. et al., Chemical Induction of Cancer: Structural Bases and Biological Mechanisms, Vol. IIIC, Natural, Metal, Fiber, and Macromolecular Carcinogens, Academic Press, New York, 1988.
11. Woo, Y.-T. et al., Carcinogenicity of organophosphorus pesticides/compounds: an analysis of their structure-activity relationships, Environ. Carcino. Ecotoxicol. Rev., C14, 1, 1996.
12. Woo, Y.-T. and Lai, D.Y., Aromatic amino and nitroamino compounds and their halogenated derivatives, in Patty’s Toxicology, Bingham, B., Cohrssen, B., and Powell, C.H., Eds., John Wiley & Sons, New York, 2001, 969.
13. Cunningham, A.R. et al., Identification of ‘genotoxic’ and ʼnongenotoxic’ alerts for cancer in mice: the carcinogenic potency database, Mutat. Res., 398, 1, 1998.
14. Lijinsky, W., Chemistry and Biology of N-Nitroso Compounds, Cambridge University Press, Cambridge, U.K., 1992.
15. Toth, B., A review of the natural occurrence, synthetic production and use of carcinogenic hydrazines and related chemicals, In Vivo, 14, 299, 2000.
16. Warshawsky, D., Environmental sources, carcinogenicity, mutagenicity, metabolism and DNA binding of nitrogen and sulfur heterocyclic aromatics, Environ. Carcino. Ecotoxicol. Rev., C10, 1, 1992.
17. Sugimura, T., Sato, S., and Wakabayashi, K., Mutagens/carcinogens in pyrolysates of amino acids and proteins and in cooked foods: heterocyclic aromatic amines, in Chemical Induction of Cancer: Structural Bases and Biological Mechanisms, Vol. IIIC, Natural, Metal, Fiber, and Macromolecular Carcinognes, Woo, Y.-T. et al., Eds., Academic Press, New York, 1988, 681
18. Fu, P.P. and Herreno-Saenz, D., Nitro-polycyclic aromatic hydrocarbons: a class of genotoxic environmental pollutants, Environ. Carcino. Ecotoxicol. Rev., C17, 1, 1999.
19. Fu, P.P. et al., Genotoxic pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides: mechanisms leading to DNA adduct formation and tumorigenicity, Environ. Carcino. Ecotoxicol. Rev., C19, 353, 2001.
20. Pennining, T.M. et al., Dihydrodiol hydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones, Chem. Res. Toxicol., 12, 1, 1999.
21. Melendez-Colon, V.J. et al., Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites, Carcinogenesis, 20, 1885, 1999.
22. Cavalieri, E.L., Higginbotham, S., and Rogan, E.G., Dibenzo[a, l]pyrene: the most potent carcinogenic aromatic hydrocarbon, Polycyclic Aromat. Compounds, 6, 177, 1994.
23. Sundberg, K. et al., Glutathione conjugation and DNA adduct formation of dibenzo[a, l]pyrene and benzo[a]pyrene diol epoxides in V79 cells stably expressing different human glutathione transferases, Chem. Res. Toxicol., 15, 170, 2002.
24. Ruan, Q. et al., Synthesis and characterization of site-specific and stereoisomeric fjord dibenzo[a, l]pyrene diol epoxide-N6-adenine adducts: unusual thermal stabilization of modified DNA duplexes, Chem. Res. Toxicol., 15, 249, 2002.
25. Chakravarti, D. et al., Evidence that error-prone DNA repair converts dibenzo[a, l]pyrene-induced depurinating lesions into mutations: formation, clonal proliferation and repression of initiated cells carry H-ras oncogene mutations in early preneoplasia, Mutat. Res., 456, 17, 2000.
26. Cavalieri, E.L. and Rogan, E.G., Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons, Xenobiotica, 25, 677, 1995.
27. Newnow, S. et al., 8,9-Dihydroxy-8,9-dihydrodibenzo[a, l]pyrene is a potent morphological cell-transforming agent in C3H10T1/2C18 mouse embryo fibroblasts in the absence of detectable stable covalent DNA adducts, Carcinogenesis, 21, 1253, 2000.
28. Padgett, W.T. et al., Biotransformation of trans-4,5-dihydroxy-4,5-dihydrobenzo[ a]pyrene to benzo[a]pyrene bis-diols and DNA adducts by induced rat liver microsomes, Chem. Res. Toxicol., 11, 1125, 2000.
29. Stansbury, K.H. et al., Enzyme-mediated dialdehyde formation: an alternative pathway for benzo[a]pyrene 7,8-dihydrodiol bioactivation, Chem. Res. Toxicol., 13, 1174, 2000.
30. Flesher, J.W., Horn, J., and Lehner, A.F., 9-Sulfooxymethylanthracene is an ultimate electrophilic and carcinogenic form of 9-hydroxymethylanthracene, Biochem. Biophys. Res. Commun., 251, 339, 1998.
31. Bentley, P. et al. Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol., 31, 857, 1993.
32. Lake, B.G. et al., Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset, Toxicol. Appl. Pharmacol., 99, 148, 1989.
33. Rao, M.S. and Reddy, J.K., Hepatocarcinogenesis of the peroxisome proliferators. Ann. N.Y. Acad. Sci., 804, 573, 1996.
34. Ashby, J., et al., Mechanistically based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis, Human Exp. Toxicol., 13 (suppl. 2), S1, 1994.
35. Lake, B.G. and Lewis, D.F.V., Structure-activity relationships for chemically induced peroxisome proliferation in mammalian liver, in Peroxisomes: Biology and Importance in Toxicology and Medicine, Gibson, G. and Lake, B. Eds., Taylor & Francis, London, 1993, chap. 14.
36. Reddy, J.K. and Lalwai, N.D., Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans, CRC Crit. Rev. Toxicol., 12, 1, 1983.
37. Lake, B.G. et al., Structure-activity relationships for induction of peroxisomal enzyme activities in primary rat hepatocyte cultures, Toxicol. In Vitro, 7, 605, 1993.
38. Cattley, R.C. et al., Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?, Regul. Toxicol. Pharmacol., 97, 47, 1998.
39. Marsman, D.S. et al., Relation of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferator di(2- ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,642) in rats, Cancer Res., 48, 6739, 1988.
40. Lake, B.G. et al., Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-b1 gene expression in the rat, Syrian hamster and guinea pig, Mutat. Res., 448, 213, 2000.
41. Rose, M.L. et al., Role of Kupffer cells and oxidants in signaling peroxisome proliferator- induced hepatocyte proliferation, Mutat. Res., 448, 179, 2000.
42. Peters, J.M., Cattley, R.C., and Gonzalez, F.J., Role of PPAR in the mechanism of action of the nongenotoxic carcinogen peroxisome proliferator WY-14,643, Carcinogenesis, 18, 2029, 1997.
43. Corton, J.C., Lappinskas, P.J., and Gonzalez, F.J., Central role of PPAR in the mechanism of action of hepatocarcinogenic peroxisome proliferators, Mutat. Res., 448, 139, 2000.
44. Van den Heuvel, J.P., Peroxisome proliferator-activated receptors (PPARs) and carcinogenesis, Toxicol. Sci., 47, 1, 1999.
45. IARC, Peroxisome Proliferation and Its Role in Carcinogenesis, IARC Technical Report No. 24, International Agency for Research on Cancer, Lyon, France, 1995.
46. Poland, A., Glover, E., and Kende, A.S., Stereospecific, high affinity binding of 2,3,7,8- tetrachlorodibenzo-p-dioxin by hepatic cytosol: evidence that the binding species is receptor for induction of aryl hydrocarbon hydrolyase, J. Biol. Chem., 251, 4936, 1976.
47. Rowlands, J.C. and Gustafsson, J.-A., Aryl hydrocarbon receptor-mediated signal transduction, CRC Crit. Rev. Toxicol., 27, 109, 1997.
48. Schwarz, M. et al., Ah receptor ligands and tumor promotion: survival of neoplastic cells, Toxicol. Lett., 112-113, 69, 2000.
49. Safe, S., Molecular biology of the Ah receptor and its role in carcinogenesis, Toxicol. Lett., 120, 1, 2001.
50. Waller, C.L. and McKinney, J.D., Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: model validation and Ah receptor characterization, Chem. Res. Toxicol., 8, 847, 1995.
51. USEPA, Interim Procedures for Estimating Risks Associated with Exposures to Mixtures of Chlorinated Dibenzo-p-dioxins and Dibenzofurans (CDDs and CDFs) and 1989 Update, EPA/625/3-89/016, U.S. Environmental Protection Agency, Washington, D.C., 1989.
52. Van den Berg, M. et al., Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife, Environ. Health Persp., 106, 775, 1998.
53. Machala, M. et al., Aryl hydrocarbon receptor-mediated activity of mutagenic polycyclic aromatic hydrocarbons determined using in vitro reporter gene assay, Mutat. Res., 497, 49, 2001.
54. Dashwood, R.H., Indole-3-carbinol: anticarcinogen or tumor promoter in brassica vegetables?, Chem. Biol. Interact., 110, 1, 1998.
55. Sahu, S.C., Dual role of flavonoids in mutagenesis and carcinogenesis, Environ. Carcino. Ecotoxicol. Rev., C12, 1, 1994.
56. Woo, Y.-T., Arcos, J.C., and Lai, D.Y., Structural and functional criteria for suspecting chemical compounds of carcinogenic activity: state-of-the-art of predictive formalism, in Handbook of Carcinogen Testing, Milman, H.A. and Weisburger, E.K., Eds., Noyes, Park Ridge, NY, 1985, 1.
57. Parke, D.V. and Ioannides, C., Role of cytochrome P-450 in mouse liver tumor production, Prog. Clin. Biol. Res., 331, 215 1990.
58. Ioannides, C., Lewis, D.F., and Parke, D.V., Computer modelling in predicting carcinogenicity, Eur. J. Cancer Prev., 2, 275, 1993.
59. Lewis, D.F., Ioannides, C., and Parke, D.V., A retrospective evaluation of COMPACT predictions of the outcome of NTP rodent carcinogenicity testing, Environ. Health Persp., 103, 178, 1995.
60. Lewis, D.F. et al., Quantitative structure-activity relationships for inducers of cytochrome P450 and nuclear receptor ligands involved in P450 regulation within the CYP1, CYP2, CYP3 and CYP4 families, Toxicology, 176, 51, 2002.
61. Trosko et al., Intercellular communication: a paradigm for the interpretation of the initiation/promotion/progression model of carcinogenesis, in Chemical Induction of Cancer, Modulation and Combination Effects, Arcos, J.C., Argus, M.F., and Woo, Y.-T., Eds., Birkhauser, Boston, 1995, 205.
62. Mai, X.D. et al., Expression of gap junction genes connexin32 and connexin43 mRNAs and proteins, and their role in hepatocarcinogensis, World J. Gastroenterol., 8, 64, 2002.
63. Upham, B.L. et al., Inhibition of gap junctional intercellular communication by perfluorinated fatty acids is dependent on the chain length of the fluorinated tail, Int. J. Cancer, 78, 491, 1998.
64. Smith, J.H. et al., Comparative in vivo hepatic effects of di-isononyl phthalate (DINP) and related C7-C11 dialkyl phthalates on gap junctional intercellular communication (GJIC), peroxisomal beta-oxidation (PBOX), and DNA synthesis in rat and mouse liver, Toxicol. Sci., 54, 312, 2000.
65. Upham, B.L. et al., The effects of anthracene and methylated anthracenes on gap junctional intercellular communiation in rat liver epithelial cells, Fund. Appl. Toxicol., 34, 260, 1996.
66. Upham, B.L., Weis, L.M., and Trosko, J.E., Modulated gap junctional intercellular communication as a biomarker of PAH epigenetic toxicity: structure-function relationship, Environ. Health Persp., 106 (suppl. 4), 975, 1998.
67. Rummel, A.M. et al., Polycyclic aromatic hydrocarbons with bay-like regions inhibited gap junctional intercellular communication and stimulated MAPK actiity, Toxicol. Sci., 49, 232, 1999.
68. Blaha, L. et al., Inhibition of gap-junctional intercellular communication by environmentally occurring polycyclic aromatic hydrocarbons, Toxicol. Sci., 65, 43, 2002.
69. LaVoie, E.J. et al., Tumorigenic activity of fluoranthene, 2-methylfluoranthene, and 3-methylfluoranthene in newborn CD-1 mice, Carcinogenesis, 15, 2131, 1994.
70. Sai, K. et al., Inhibitory effect of pentachlorophenol on gap junctional intercellular communication in rat liver epithelial cells in vitro, Cancer Lett., 130, 9, 1998.
71. Masten, S.J. et al., Effect of selected pesticides and their ozonation by-products on gap junctional intercellular communication in rat liver epithelial cell lines, Chemosphere, 44, 457, 2001.
72. Kovacic, P. and Jacintho, J.D., Mechanisms of carcinogenesis: focus on oxidative stress and electron electron, Curr. Med. Chem., 8, 773, 2001.
73. Klaunig, J.E. et al., The role of oxidative stress in chemical carcinogenesis, Environ. Health Persp., 106 (suppl. 1), 289, 1998.
74. Poulsen, H.E., Prieme, H., and Loft, S., Role of oxidative DNA damage in cancer initiation and promotion, Eur. J. Cancer Prevention 7, 9, 1998.
75. Upham, B.L. and Wagner, J.G., Toxicant-induced oxidative stress in cancer, Toxicol. Sci., 64, 1, 2001.
76. Nordberg, J. and Arner, E.S.J., Reactive oxygen species, antioxidants, and the mammalian thioredoxin system, Free Radicals Biol. Med., 31, 1287, 2001.
77. Floyd, R.A., The role of 8-hydroxyguanine in carcinogenesis, Carcinogenesis, 11, 1447, 1990.
78. Pi, J. et al., Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water, Environ. Health Persp., 110, 331, 2002.
79. Gottschling, B.C. et al., The role of oxidative stress in indium phosphide-induced lung carcinogenesis in rats, Toxicol. Sci., 64, 28, 2001.
80. Cherng, S.H. et al., Human 8-oxoguanine DNA glycosylase 1 mRNA expression as an oxidative stress exposure biomarker of cooking oil fumes, J. Toxicol. Environ. Health, A65, 265, 2002.
81. Kawanishi, S., Hiraku, Y., and Oikawa, S., Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging, Mutat. Res., 488, 65, 2001.
82. Hsu, T.C. et al., Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)- dependent transcriptional events in carcinogenesis, Free Radicals Biol. Med., 28, 1338, 2000.
83. Barouki, R. and Morel, Y., Oxidative stress and gene expression, J. Soc. Biol., 195, 377, 2001.
84. Twaroski, T.P., O’Brien, M.K., and Robertson, L.W., Effects of selected polychlorinated biphenyl congeners on hepatic glutathione, glutathione-related enzymes, and selenium status: implications for oxidative stress, Biochem. Pharmacol., 62, 273, 2001.
85. Gopalakrishna, R. and Jaken, S., Protein kinase C signaling and oxidative stress, Free Radicals Biol. Med., 28, 1349, 2000.
86. Orucevic, A. et al., Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness, Int. J. Cancer, 81, 889, 1999.
87. Franchi, A. et al., Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis, Head Neck, 24, 16, 2002.
88. Lai, D.Y. et al., Carcinogenic potential of organic peroxides: prediction based on structure-activity relationships (SAR) and mechanism-based short-term tests, Environ. Carcino. Ecotoxicol. Rev., C14, 63, 1996.
89. Buzard, G.S. and Kaprzak, K.S., Possible roles of nitric oxide and redox cell signaling in metal-induced toxicity and carcinogenesis: a review, J. Environ. Pathol. Toxicol. Oncol., 19, 179, 2000.
90. Iqbal, M. et al., Evidence that ferric nitrilotriacetate mediates oxidative stress by down-regulating DT-diaphorase activity: implications for carcinogenesis, Cancer Lett., 141, 151, 1999.
91. Shi, X. et al., Reactive oxygen species and silica-induced carcinogenesis, J. Toxicol. Environ. Health, Part B, Crit. Rev., 1, 181, 1998.
92. Cadenas, S. and Barja, G., Resveratrol, melatonin, vitamin E, and PBN protect against renal oxidative DNA damage induced by the kidney carcinogen KBrO3, Free Radical Biol. Med., 26, 1531, 1999.
93. Goodman, J.I. and Watson, R.E., Altered DNA methylation: a secondary mechanism involved in carcinogenesis, Annu. Rev. Pharmacol. Toxicol., 42, 501, 2002.
94. Watson, R.E. and Goodman, J.I., Epigenetics and DNA methylation come of age in toxicology, Toxicol. Sci., 67, 11, 2002.
95. Klein, C.B. and Costa, M., DNA methylation, heterochromatin and epigenetic carcinogens, Mutat. Res., 386, 163, 1997.
96. Wachsman, J.T., DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis, Mutat. Res., 375, 1, 1997.
97. Zhong, C.X. and Mass, M.J., Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylationsensitive arbitrarily-primed PCR, Toxicol. Lett., 122, 223, 2001.
98. Chuang, L.S. et al., Selective depletion of human DNA-methyltransferase DNMT1 proteins by sulfonate-derived methylating agents, Cancer Res., 62, 1592, 2002.
99. Wilson, V.L. et al., Chemical carcinogen-induced decreases in genomic 5-methyldeoxycytidine content of normal human bronchial epithelial cells, Proc. Nat. Acad. Sci. USA, 84, 3298, 1987.
100. Nyce, J., Drug-induced DNA hypermethylation and drug resistance in human tumors, Cancer Res., 49, 5829, 1989.
101. Yerokun, T., Lyn-Cook, B.D., and Ringer, D.P., Hypomethylation of the rat aryl sulfotransferase IV gene and amplification of a DNA sequence during multistage 2- acetylaminofluorene hepatocarcinogenesis, Chem. Biol. Interact., 92, 363, 1994.
102. Counts, J.L., McClain, R.M., and Goodman, J.I., Comparson of effect of tumor promoter treatments on DNA methylation status and gene expression in B6CeF1 and C57Bl/6 mouse liver and in B6C3F1 mouse liver tumors, Molec. Carcinogen., 18, 97, 1997.
103. Counts, J.L. et al., Cell proliferation and global methylation status changes in mouse liver after phenobarbital and/or choline-devoid, methionine-deficient diet administration, Carcinogenesis, 17, 1251, 1996.
104. Tao, L. et al., Effect of trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-jun and c-myc protooncogenes in mouse liver: prevention by methionine, Toxicol. Sci., 54, 399, 2000.
105. Coffin, J.C. et al., Effect of trihalomethanes on cell proliferation and DNA methylation in female B6C3f1 mouse liver, Toxicol. Sci., 58, 243, 2000.
106. Govindarajan, B. et al., Reactive oxygen-induced carcinogenesis causes hypermethylation of p16 and activation of MAP kinase, Molec. Med., 8, 1, 2002.
107. Cangul, H. et al., Molecular mechanisms of nickel carcinogenesis, Toxicol. Lett., 127, 69, 2002.
108. Zhao, C.Q. et al., Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression, Proc. Nat. Acad. Sci. USA, 94, 10907, 1997.
109. Chen, H. et al., Assocation of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation, Toxicol. Appl. Pharmacol., 175, 260, 2001.
110. Lu, G., Cai, Q., and Zhang, W., Effects of inorganic arsenicals on the methylation of p16 gene CpG islands and the expression of p16 gene in BEP2D cells, Zhonghua Yi Xue Za Zhi, 81, 1238, 2001.
111. Mass, M.M.J. and Wang, A.L., Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis, Mutat. Res., 386, 263, 1997.
112. Okoji, R.S. et al., Sodium arsenite administration via drinking water increases genome-wide and Ha-ras DNA hypomethylation in methyl-deficient C57B/6 J mice, Carcinogenesis, 23, 777, 2002.
113. Li, J.J. and Li, S.A. The effect of hormones on tumor induction, in Chemical Induction of Cancer, Modulation and Combination Effects, Arcos, J.C., Argus, M.F., and Woo, Y.-T., Eds., Birkhauser, Boston, 1995, 397.
114. USEPA, Assessment of Thyroid Follicular Cell Tumors, EPA/630/R-97/002, U.S. Environmental Protection Agency, Washington, D.C., 1998.
115. Rice, J.M. et al., Rodent tumors of urinary bladder, renal cortex, and thyroid gland in IARC Monographs Evaluations of Carcinogenic Risk to Humans, Toxicol. Sci., 49, 166, 1999.
116. Hill, R.N. et al., Thyroid follicular cell carcinogenesis, Fund. Appl. Toxicol., 12, 629, 1989.
117. Hill, R.N. et al., Risk assessment of thyroid follicular cell tumors, Environ. Health Persp., 106, 447, 1998.
118. McClain, R.M., Thyroid gland neoplasia: non-genotoxic mechanisms, Toxicol. Lett., 64/65, 397, 1992.
119. Hard, G.C., Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis, Environ. Health Persp., 106, 427, 1998.
120. Hurley, P.M., Hill, R.N., and Whiting, R.J., Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents, Environ. Health Persp., 106, 437, 1998.
121. Clegg, E.D. et al., Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans, Reproductive Toxicol., 11, 107, 1997.
122. Cook, J.C. et al., Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans, CRC Crit. Rev. Toxicol., 29, 169, 1999.
123. Capen, C.C. et al., Mechanisms of hormone-mediated carcinogenesis of the ovary in mice, Mutat. Res., 333, 143, 1995.
124. Long, G.G. et al., Proliferative lesions of ovarian granulose cells and reversible hormonal changes induced in rats by a selective estrogen receptor modulator, Toxicol. Pathol., 29, 719, 2001.
125. Takegawa, K. et al., A mechanistic study of ovarian carcinogenesis induced by nitrofurazone using rasH2 mice, Toxicol. Pathol., 28, 649, 2000.
126. Combe, R.D., The use of structure-activity relationships and markers of cell toxicity to detect non-genotoxic carcinogens, Toxicol. In Vitro, 14, 387, 2000.
127. Rosenkranz, H.S. et al., Identification of a 2-D geometric descriptor associated with non-genotoxic carcinogens and some estrogens and antiestrogens, Mutagenesis, 11, 95, 1996.
128. Cunningham, A.R. et al., Structural analysis of a group of phytoestrogens for the presence of a 2-D geometric descriptor associated with non-genotoxic carcinogens and some estrogens, Proc. Soc. Exp. Biol. Med., 217, 288, 1998.
129. Mekenyan, O.G. et al., A computationally based identification algorithm for estrogen receptor ligands. Part 2. Evaluation of a hERa binding affinity model, Toxicol. Sci., 58, 270, 2000.
130. Hong, H. et al., Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alert, Environ. Health Persp., 110, 29, 2002.
131. Connor, K. et al., Failure of chloro-s-triazine-derived compounds to induce estrongenic responses in vivo and in vitro, in Triazine Herbicides: Risk Assessment, Ballantine, L.G., McFarland, J.E., and Hackett, D.S., Eds., American Chemical Society, Washington, D.C., 1998, chap. 33, p. 424.
132. O’Connor, J.C. et al., Role of prolactin in chloro-s-triazine rat mammary tumorigenesis, Drug Chem. Toxicol., 23, 575, 2000.
133. IARC, Atrazine, IARC Monogr., 73, 59, 1999.
134. Wang, D.Y. et al., Relationship of blood prolactin levels and the risk of subsequent breast cancer, Int. J. Epidemiol., 21, 214, 1992.
135. Barter, J.A. and Sherman, J.H., An evaluation of the carcinogenic hazard of 1,4- dichlorobenzene based on internationally recognized criteria, Regul. Toxicol. Pharmacol., 29, 64, 1999.
136. Blumbach, K. et al., Biotransformation and male rat-specific renal toxicity of diethyl ethyl- and dimethyl methylphosphonate, Toxicol. Sci., 53, 24, 2000.
137. Hard, G.C. and Whysner, J., Risk assessment of d-limonene: an example of male ratspecific renal tumorigens, CRC Crit. Rev. Toxicol., 24, 231, 1994.
138. Swenberg, J.A. and Lehman-McKeeman, L.D., Alpha-2-urinary-globulin-associated nephropathy as a mechanism of renal tubule cell carcinogenesis in male rats, IARC Sci. Publ., 147, 95, 1999.
139. USEPA, Alpha-2u-Globulin: Association with Chemical Induced Renal Toxicity and Neoplasia in the Male Rat, EPA/625/3-91/019F, Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, D.C., 1991.
140. Takahashi, K., Lindamood III, C., and Maronpot, R.R., Retrospective study of possible alpha-2m-globulin nephropathy and associated cell proliferation in male Fischer 344 rats dosed with t-butyl alcohol, Environ. Health Persp., 101 (suppl. 5), 281, 1993.
141. Borghoff, S.J. et al., Characteristics of chemical binding to a2m-globulin in vitro - structure-activity relationships, Toxicol. Appl. Pharmacol., 107, 228, 1991.
142. DeSesso, J.M., Confounding factors in direct bladder exposure studies, Comments Toxicol., 3, 317, 1989.
143. Cohen, S.M. et al., Comparative bladder tumour promoting activity of sodium saccharin, sodium ascorbate related acids, and calcium salts in rats, Cancer Res., 51,1766, 1991.
144. Cohen, S.M. et al., Tumorigenicity of sodium ascorbate in male rats, Cancer Res., 58, 2557, 1998.
145. Shioya, S., Roles of bladder distension, urinary pH and urinary sodium ion concentration in cell proliferation of urinary bladder epithelium in rats ingesting sodium salts, Food Chem. Toxicol., 32, 165, 1994.
146. Cohen, S.M. et al., A proposed role for silicates and protein in the proliferative effects of saccharin on the male rat urothelium, Carcinogenesis, 12, 1551, 1991.
147. Cohen, S.M., Calcium-phosphate-containing urinary precipitate in rat urinary bladder carcinogenesis, IARC Sci. Publ., 147, 175, 1999.
148. Cohen, S.M. et al., Calcium-phosphate-containing precipitate and the carcinogenicity of sodium salts in rats, Carcinogenesis, 21, 783, 2000.
149. Okamura, M. et al., Relationship between calculus formation and carcinogenesis in the urinary bladder of rats administered the nongenotoxic agents thymine or melamine, Carcinogenesis, 13, 1043, 1992.
150. Shibata, M.A. et al., Progressive growth of rat bladder carcinomas after exposure to prolonged uracil-induced urolithiasiis, Teratog. Carcinog. Mutagen., 14, 157, 1994.
151. Fukushima, S. and Murai, T., Calculi, precipitates and microcrystalluria associated with irritation and cell proliferation as a mechanism of urinary bladder carcinogenesis in rats and mice, IARC Sci. Publ., 147, 159, 1999.
152. Anderson, R.L. and Kanerva, R.L., Hypercalcinuria and crystalluria during ingestion of dietary nitrilotriacetate, Food Cosmet. Toxicol., 16, 569, 1979.
153. Iqbal, M. et al., Evidence that ferric nitrilotriacetate mediates oxidative stress by down-regulating DT-diaphorase activity: implications for carcinogenesis, Cancer Lett., 141, 151, 1999.
154. Fujii, T., Nakamura, K., and Hiraga, K., Effects of pH on the carcinogenicity of ophenylphenol and sodium o-phenylphenate in the rat urinary bladder, Food Chem. Toxicol., 25, 359, 1987.
155. Appel, K.E., The carcinogenicity of the biocide ortho-phenylphenol, Arch. Toxicol., 74, 61, 2000.
156. Heck, H.D. and Tyl, R.W., The induction of bladder stones by terephthalic acid, dimethyl terephthalate, and melamine and its relevance to risk assessment, Regul. Toxicol. Pharmacol., 5, 294, 1985.
157. Flaks, A., Hamilton, J.M., and Clayson, D.B., Effect of ammonium chloride on incidence of bladder tumors induced by 4-ethylsulfonylnaphthalene-1-sulfonamide, J. Natl. Cancer Inst., 51, 2007, 1973.
158. Burnett, C.M. and Squire, R.A., The effect of dietary administration of disperse blue 1 on the urinary system of the Fischer 344 rat, Food Chem. Toxicol., 24, 269, 1986.
159. Toyoda, K. et al., Relationship between bisacodyl-induced urolithiasis and rat urinary bladder tumorigenesis, J. Toxicol. Environ. Health, 39, 59, 1993.
160. Larson, J.L., Wolf, D.C., and Butterworth, B.E., Induced cytolethality and regenerative cell proliferation in the livers and kidneys of male B6C3F1 mice given chloroform by gavage, Fund. Appl. Toxicol., 23, 537, 1994.
161. Templin, M.V. et al., Patterns of chloroform-induced regenerative cell proliferation in BDF1 mice correlate with organ specificity and dose-response of tumor formation, Carcinogenesis, 19, 187, 1998.
162. Melnick, R.L. et al., Regenerative hyperplasia is not required for liver tumor induction in female B6C3F1 mice exposed to trihalomethane, Toxicol. Appl. Pharmacol., 148, 137, 1998.
163. Bus, J.S. and Popp, J.A., Perspectives on the mechanism of action of the splenic toxicity of aniline and structurally-related compounds, Food Chem. Toxicol., 25, 619, 1987.
164. Goodman, D.G., Ward, J.M., and Reichardt, W.D., Splenic fibrosis and sarcomas in F344 rats fed diets containing aniline hydrochloride, p-chloroaniline, azobenzene, otoluidine hydrochloride, 4,4¢-sulfonyldianiline, or D&C red no. 9, J. Natl. Cancer Inst., 73, 265, 1984.
165. Weinberger, M.A., Albert, R.H., and Montgomery, S.B., Splenotoxicity associated with splenic sarcomas in rats fed high doses of D&C red no. 9 or aniline hydrochloride, J. Natl. Cancer Inst., 75, 681, 1985.
166. Heydens, W.F. et al., An evaluation of the carcinogenic potential of the herbicide alachlor to man, Human Exp. Toxicol., 18, 363, 1999.
167. Green, T. et al., Acetochlor-induced rat nasal tumors: further studies on the mode of action and relevance to humans, Regul. Toxicol. Pharmacol., 32, 127, 2000.
168. Woo, Y.T. et al., An integrative approach of combining mechanistically complementary short-term predictive tests as a basis for assessing the carcinogenic potential of chemicals, Environ. Carcino. Ecotoxicol. Rev., C16, 101, 1998.
169. Burnet, F.M., The concept of immunological surveillance, Prog. Exp. Tumor Res., 13, 1, 1970.
170. Sullivan, K.A. and Salvaggio, J.E., Immunotoxicology of chemical carcinogens, in Chemical Induction of Cancer, Modulation and Combination Effects, Arcos, J.C., Argus, M.F., and Woo, Y.-T., Eds., Birkhauser, Boston, 1995, 237.
171. Botti, C. et al., Immunosuppressive factors: role in cancer development and progression, Int. J. Biol. Markers, 13, 51, 1998.
172. Stinchcombe, S. et al., Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-pdioxin- mediated tumor promotion in rat liver, Carcinogenesis, 16, 1271, 1995.
173. Camacho, I.A. et al., Enhanced activation-induced cell death as a mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity in peripheral T cells, Toxicology, 165, 51, 2001.
174. Dragan, Y.P. et al., Implications of apoptosis for toxicity, carcinogencity, and risk assessment: fumonisin B1 as an example, Toxicol. Sci., 61, 6, 2001.
175. Jull, B.A., Plummer III, H.K., and Schuller, H.M., Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells, J. Cancer Res. Clin. Oncol., 127, 707, 2001.
176. Woo, Y.-T. et al., Mechanism-based structure-activity relationship (SAR) analysis of carcinogenic potential of 30 NTP test chemicals, Environ. Carcino. Ecotoxicol. Rev., C15, 139, 1997.
177. Richard, A.M. and Benigni, R., AI and SAR approaches for predicting chemical carcinogenicity: survey and status report, SAR QSAR in Environ. Res., 13, 1, 2002.
178. Buchiel, S.W. et al., Analysis of genetic and epigenetic mechnaisms in toxicity: potential roles of toxicogenomics and proteomics in toxicology, Toxicol. Sci., 59, 193, 2001.
179. Fielden, M.R. and Zacharewski, T.R., Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology, Toxicol. Sci., 60, 6, 2001.
180. Larsen, J.C., Farland, W., and Winters, D., Current risk assessment approaches in different countries, Food Additive Contam., 17, 359, 2000.
181. USEPA, Guidelines for Carcinogen Risk Assessment: Revised Draft, U.S. Environmental Protection Agency, Washington, D.C., 1999 (available online at www.epa.gov/ncea).
182. Greim, H. and Reuter, U., Classification of carcinogenic chemicals in the work area by the German MAK Commission: current examples for the new categories, Toxicology, 166, 11, 2001.
183. Lai, D. et al., Cancer risk reduction through mechanism-based molecular design of chemicals, in Designing Safer Chemicals, DeVito, S.C. and Garrett, R.L., Eds., ACS Symposium Series 640, American Chemical Society, Washington, D.C., 1996, p. 62.